AH

Adam D. Hughes

TI Theravance Biopharma R&D Ip: 78 patents #1 of 116Top 1%
TH Theravance: 46 patents #10 of 116Top 9%
TC Theravance Respiratory Company: 12 patents #1 of 9Top 15%
📍 Rue de l'Église, CA: #3 of 378 inventorsTop 1%
🗺 California: #1,207 of 386,348 inventorsTop 1%
Overall (All Time): #7,613 of 4,157,543Top 1%
136
Patents All Time

Issued Patents All Time

Showing 1–25 of 136 patents

Patent #TitleCo-InventorsDate
12351561 Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, R. Michael Baldwin, David L. Bourdet 2025-07-08
12016835 Neprilysin inhibitors Erik Fenster, Melissa Fleury, Roland Gendron, Edmund J. Moran 2024-06-25
11919888 Neprilysin inhibitors Melissa Fleury 2024-03-05
11851443 Neprilysin inhibitors Roland Gendron, Melissa Fleury 2023-12-26
11730720 ALK5 inhibitors Svitlana Kulyk, Christina Owens, Steven D. E. Sullivan, Jennifer Kozak 2023-08-22
11718591 Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone +2 more 2023-08-08
11673879 Substituted pyrimidines and methods of use Mandy Loo, Svitlana Kulyk, Christopher BAILEY, Jennifer Kozak, Matthew B. Soellner 2023-06-13
11642332 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2023-05-09
11634413 Neprilysin inhibitors Melissa Fleury 2023-04-25
11590116 Substituted pyridines and methods of use Christina Owens, Svitlana Kulyk, Steven D. E. Sullivan, Paul Allegretti, Mandy Loo +2 more 2023-02-28
11547687 Neprilysin inhibitors Erik Fenster, Melissa Fleury, Roland Gendron, Edmund J. Moran 2023-01-10
11261197 Neprilysin inhibitors Roland Gendron, Melissa Fleury 2022-03-01
11230536 Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi 2022-01-25
11174219 Neprilysin inhibitors Melissa Fleury 2021-11-16
11124502 Neprilysin inhibitors Melissa Fleury 2021-09-21
11033533 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2021-06-15
10952996 ALK5 inhibitors Svitlana Kulyk, Christina Owens, Steven D. E. Sullivan, Jennifer Kozak 2021-03-23
10836744 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more 2020-11-17
10829438 Neprilysin inhibitors Melissa Fleury 2020-11-10
10759813 Neprilysin inhibitors Roland Gendron 2020-09-01
10752599 Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone 2020-08-25
10744104 Neprilysin inhibitors Erik Fenster, Melissa Fleury, Roland Gendron, Edmund J. Moran 2020-08-18
10590107 Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more 2020-03-17
10570120 Neprilysin inhibitors Melissa Fleury 2020-02-25
10548879 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2020-02-04